NDC11 71773010005
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 71773-0100-05 | 71773-0100 |
| 71773-0100-5 | 71773-0100 |
| 71773-100-05 | 71773-100 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Xerava | ERAVACYCLINE | Tetraphase Pharmaceuticals, Inc. | a4b188d4-f467-470c-ad7b-25ffbdd8862a | 2025-03-31 | Warnings, Adverse reactions | 71773-100-05 71773-100 71773010005 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.